Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. On the Frontlines of Food Allergies

Reducing Food Allergy Reactions with an Asthma Treatment

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Omalizumabwas originally approved in 2003 to treat asthma and subsequently has been approved to treat patients who have other allergic conditions. Moreover, numerous small studies over the years have suggested this drug could significantly impact reactions that patients might have to food exposures. To learn more about the impact of omalizumab on food allergy reactions, join Dr. Brian McDonough as he speaks with Dr. Robert Wood, Professor of Pediatrics at Johns Hopkins University School of Medicine and Chief of the Eudowood Division of Allergy and Immunology in the Johns Hopkins Children’s Center. 

Recommended
Details
Presenters
Comments
  • Overview

    Omalizumabwas originally approved in 2003 to treat asthma and subsequently has been approved to treat patients who have other allergic conditions. Moreover, numerous small studies over the years have suggested this drug could significantly impact reactions that patients might have to food exposures. To learn more about the impact of omalizumab on food allergy reactions, join Dr. Brian McDonough as he speaks with Dr. Robert Wood, Professor of Pediatrics at Johns Hopkins University School of Medicine and Chief of the Eudowood Division of Allergy and Immunology in the Johns Hopkins Children’s Center. 

Schedule14 Oct 2024